Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

ICR responds to Government’s Life Sciences Industrial Strategy

Posted on: 31 Aug 17

The Institute of Cancer Research, London, today responds to the publication of the Life Sciences Industrial Strategy. The Institute of Cancer Research (ICR) responded to the UK Government’s January 2017 green paper proposing how they intend to build a modern industrial strategy. The ICR submitted a number of comments and recommendations to ensure that the political and economic environment remains favourable for conducting and translating cancer research.

Professor Paul Workman, Chief Executive of The Institute of Cancer Research, London, said:

“We’re very pleased to see many of the ICR’s recommendations are reflected in the Life Sciences Industrial Strategy. The fact the life sciences are the first to have an industrial strategy recognises the strength of the sector’s collaborations between industry and academia.

“The ICR, as an academic institution, has long recognised the importance of working with industry to ensure our discoveries benefit people with cancer as soon as possible. Commercialising our scientific discoveries is therefore essential to a successful industrial strategy and we support the focus on growing the economy through investing in science. Projects like The London Cancer Hub, a biocampus which aims to bring together industry, the NHS and academia on one site, will be key to implementing the strategy.

“We welcome the focus on supporting basic science. The UK has a rich heritage of blue skies research – particularly in innovative cancer discoveries – which will only continue if scientists get the funding they need. It’s vital that the discovery pipeline fuelling clinical breakthroughs is not shut off.

“The financial announcements are crucial but, for the UK, and global institutions like the ICR, to remain competitive, we need to be able to attract and retain the brightest and the best. We look forward to hearing more about the Government’s plans for ensuring the UK continues to be a beacon for skilled scientists from within the EU and beyond.”

Editor's Details

Mike Wood

Last updated on: 31/08/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.